Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · Real-Time Price · USD
1.020
-0.030 (-2.86%)
Mar 31, 2026, 12:39 PM EDT - Market open
Nuwellis Revenue
In the year 2025, Nuwellis had annual revenue of $8.27M, down -5.38%. Nuwellis had revenue of $2.42M in the quarter ending December 31, 2025, with 4.39% growth.
Revenue (ttm)
$8.27M
Revenue Growth
-5.38%
P/S Ratio
0.29
Revenue / Employee
$217,632
Employees
38
Market Cap
2.36M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.27M | -470.00K | -5.38% |
| Dec 31, 2024 | 8.74M | -124.00K | -1.40% |
| Dec 31, 2023 | 8.86M | 321.00K | 3.76% |
| Dec 31, 2022 | 8.54M | 622.00K | 7.85% |
| Dec 31, 2021 | 7.92M | 480.00K | 6.45% |
| Dec 31, 2020 | 7.44M | 1.93M | 35.02% |
| Dec 31, 2019 | 5.51M | 513.00K | 10.26% |
| Dec 31, 2018 | 5.00M | 1.45M | 40.67% |
| Dec 31, 2017 | 3.55M | 2.26M | 175.64% |
| Dec 31, 2016 | 1.29M | 1.23M | 2,084.75% |
| Dec 31, 2015 | 59.00K | -236.00K | -80.00% |
| Dec 31, 2014 | 295.00K | 236.00K | 400.00% |
| Dec 31, 2013 | 59.00K | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | 407.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WORK Medical Technology Group LTD | 9.85M |
| INVO Fertility | 6.94M |
| Biomerica | 4.46M |
| Intelligent Bio Solutions | 3.58M |
| ENvue Medical | 2.69M |
| Catheter Precision | 730.00K |
| Co-Diagnostics | 507.89K |
| Tivic Health Systems | 482.00K |
NUWE News
- 4 hours ago - Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone - GlobeNewsWire
- 14 days ago - Nuwellis Completes Acquisition of Rendiatech - GlobeNewsWire
- 21 days ago - Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 26 days ago - Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy - GlobeNewsWire
- 4 weeks ago - Nuwellis Appoints David A. McDonald and Martin J. - GlobeNewsWire
- 5 weeks ago - Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026 - GlobeNewsWire
- 2 months ago - Nuwellis Appoints Carisa Schultz as Chief Financial Officer - GlobeNewsWire
- 2 months ago - Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market - GlobeNewsWire